Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Southwest Airlines Q2 Earnings Beat Estimates on Record Revenue Growth
Southwest Airlines Q2 Earnings Beat Estimates on Record Revenue Growth

Southwest Airlines Co. (LUV) reported second-quarter 2026 adjusted earnings of 94 cents per share, up 118.6% year over year and 80.8% above the Zacks Consensus Estimate of 52 cents. Record operating

Weatherford Q2 Earnings Miss Estimates on Middle East Disruptions
Weatherford Q2 Earnings Miss Estimates on Middle East Disruptions

Weatherford International plc WFRD reported second-quarter 2026 earnings of 55 cents per share, down 70.6% from $1.87 a year ago. The bottom line missed the Zacks Consensus Estimate of 92 cents by

4 Software Stocks Poised to Benefit From Expanding AI AdoptionPhoto, wide shot, wide-angle lens,  Consumer electronics manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/0defe5ca-333a-451e-9549-4f262e278fc7.png
4 Software Stocks Poised to Benefit From Expanding AI Adoption

Artificial intelligence (AI) is rapidly reshaping the global technology landscape, driving a new wave of enterprise software spending. Businesses across industries ranging from manufacturing and

Arch Capital to Report Q2 Earnings: What's in Store for the Stock?
Arch Capital to Report Q2 Earnings: What's in Store for the Stock?

Arch Capital Group Ltd. ACGL is expected to register a decrease in both top and bottom lines when it reports second-quarter 2026 results on July 28, after the closing bell.

The Zacks Consensus

CSBR vs. CTKB: Which Life Sciences Stock Has Better Long-Term Upside?
CSBR vs. CTKB: Which Life Sciences Stock Has Better Long-Term Upside?

Life sciences companies continue to operate in an environment supported by growing investment in biomedical research, increasing demand for precision medicine and continued drug discovery activity

FAF Q2 Earnings Top Estimates on Title Strength, Investment Income: https://staticx-tuner.zacks.com/images/articles/main/30/172914.webp
FAF Q2 Earnings Top Estimates on Title Strength, Investment Income

First American Financial Corporation FAF reported second-quarter 2026 operating earnings of $2.08 per share, which beat the Zacks Consensus Estimate by 15.6% and rose 35.9% year over year.

Operating

FDA Accepts BridgeBio's Filing for Rare Genetic Disease DrugPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
FDA Accepts BridgeBio's Filing for Rare Genetic Disease Drug

BridgeBio Pharma BBIO announced that the FDA has accepted its regulatory filing seeking approval for the investigational oral candidate encaleret to treat individuals living with a rare genetic

Procter & Gamble to Report Q4 Earnings: What Should You Know?
Procter & Gamble to Report Q4 Earnings: What Should You Know?

The Procter & Gamble Company PG, also known as P&G, is set to report fourth-quarter fiscal 2026 results on July 29, before the opening bell. The company is expected to have witnessed year-over-year

Do Options Traders Know Something About Agenus Stock We Don't?
Do Options Traders Know Something About Agenus Stock We Don't?

Investors in Agenus Inc. AGEN need to pay close attention to the stock based on moves in the options market lately. That is because the August 21, 2026 $19.00 Call had some of the highest implied

FDA Accepts RVMD's Filing for Daraxonrasib in Pancreatic Cancer
FDA Accepts RVMD's Filing for Daraxonrasib in Pancreatic Cancer

Revolution Medicines RVMD announced that the FDA has accepted its regulatory filing seeking approval for its lead candidate, daraxonrasib, for previously treated patients with metastatic pancreatic

Are Options Traders Betting on a Big Move in Enact Holdings Stock?
Are Options Traders Betting on a Big Move in Enact Holdings Stock?

Investors in Enact Holdings, Inc. ACT need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 15, 2026 $60.00 Call had some of the highest

NDAQ Q2 Earnings Beat Estimates on Index and FinTech Growth
NDAQ Q2 Earnings Beat Estimates on Index and FinTech Growth

Nasdaq, Inc. NDAQ reported second-quarter 2026 non-GAAP earnings of $1.07 per share, up 25% year over year. The figure beat the Zacks Consensus Estimate of 98 cents by 9.18%.Net revenues increased

Coca-Cola Q2 Earnings: Should You Buy the Stock Ahead of the Release?
Coca-Cola Q2 Earnings: Should You Buy the Stock Ahead of the Release?

The Coca-Cola Company KO is slated to report second-quarter 2026 earnings on July 28, before the opening bell. The company is expected to register year-over-year top- and bottom-line growth when it

3 Reasons Why Growth Investors Shouldn't Overlook Vertiv (VRT)
3 Reasons Why Growth Investors Shouldn't Overlook Vertiv (VRT)

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

3 Reasons Growth Investors Will Love Everpure (P)
3 Reasons Growth Investors Will Love Everpure (P)

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock

3 Reasons Why Growth Investors Shouldn't Overlook Shopify (SHOP)
3 Reasons Why Growth Investors Shouldn't Overlook Shopify (SHOP)

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock

Hamilton Lane (HLNE) is an Incredible Growth Stock: 3 Reasons Why
Hamilton Lane (HLNE) is an Incredible Growth Stock: 3 Reasons Why

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth

Here is Why Growth Investors Should Buy Fomento Economico (FMX) Now
Here is Why Growth Investors Should Buy Fomento Economico (FMX) Now

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

Is Moog (MOG.A) a Solid Growth Stock? 3 Reasons to Think "Yes"
Is Moog (MOG.A) a Solid Growth Stock? 3 Reasons to Think "Yes"

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't

Can Acute Care Strength Offset Universal Health's Rising Q2 Costs?
Can Acute Care Strength Offset Universal Health's Rising Q2 Costs?

Hospital operator Universal Health Services, Inc. UHS is set to report second-quarter 2026 results on July 27, 2026, after the closing bell. The Zacks Consensus Estimate for the to-be-reported

3 Internet Software Stocks to Buy From a Challenging IndustryPhoto, wide shot, wide-angle lens,  Consumer electronics manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/0defe5ca-333a-451e-9549-4f262e278fc7.png
3 Internet Software Stocks to Buy From a Challenging Industry
The Zacks Internet Software industry is facing meaningful execution challenges as AI adoption accelerates. One of the biggest concerns is balancing rapid software development with governance and
Halliburton's Outlook Improves as Contract Wins Fuel Global Growth Ahead
Halliburton's Outlook Improves as Contract Wins Fuel Global Growth Ahead

Halliburton Company HAL enters the second half of 2026 with a stronger international growth case and a still-uneven operating backdrop. The stock’s appeal rests on contract momentum, technology

Tractor Supply Q2 Earnings & Sales Miss Estimates, Comps Drop 1.5%
Tractor Supply Q2 Earnings & Sales Miss Estimates, Comps Drop 1.5%

Tractor Supply Company TSCO reported adjusted earnings of 81 cents per share for the second quarter of 2026, unchanged from the year-ago period. The metric lagged the Zacks Consensus Estimate of 83

HON Q2 Earnings Beat on Automation Growth, Outlook Raised
HON Q2 Earnings Beat on Automation Growth, Outlook Raised

Honeywell Technologies HON reported second-quarter 2026 adjusted earnings of $1.95 per share, which surpassed the Zacks Consensus Estimate of $1.80. The bottom line increased 10% year over year on

3 Large-Cap Value Funds for Refuge Amid Prevailing Market VolatilityPhoto, wide shot, wide-angle lens,  Gas company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/01083d82-021d-4573-8c40-0e836a0771d6.png
3 Large-Cap Value Funds for Refuge Amid Prevailing Market Volatility

Geopolitical tensions have flared up again, with the United States carrying out its 11th straight night of strikes on Iran. The renewed conflict has pushed oil prices higher, raising concerns that